These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 24338664)

  • 1. Models of multiple system atrophy.
    Fellner L; Wenning GK; Stefanova N
    Curr Top Behav Neurosci; 2015; 22():369-93. PubMed ID: 24338664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
    De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
    Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
    Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
    Kaji S; Maki T; Ishimoto T; Yamakado H; Takahashi R
    Transl Neurodegener; 2020; 9():7. PubMed ID: 32095235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
    Koga S; Dickson DW
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
    Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
    Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Multiple System Atrophy a Prion-like Disorder?
    Jellinger KA; Wenning GK; Stefanova N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
    Jellinger KA
    Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal modeling an oligodendrogliopathy--multiple system atrophy.
    Bleasel JM; Halliday GM; Kim WS
    Acta Neuropathol Commun; 2016 Feb; 4():12. PubMed ID: 26860328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approaches in multiple system atrophy.
    Palma JA; Kaufmann H
    Clin Auton Res; 2015 Feb; 25(1):37-45. PubMed ID: 24928797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.
    Teil M; Dovero S; Bourdenx M; Arotcarena ML; Camus S; Porras G; Thiolat ML; Trigo-Damas I; Perier C; Estrada C; Garcia-Carrillo N; Morari M; Meissner WG; Herrero MT; Vila M; Obeso JA; Bezard E; Dehay B
    Brain; 2022 Apr; 145(3):1001-1017. PubMed ID: 35285474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of multiple system atrophy.
    Fernagut PO; Tison F
    Neuroscience; 2012 Jun; 211():77-82. PubMed ID: 21963351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple system atrophy: alpha-synuclein and neuronal degeneration.
    Yoshida M
    Neuropathology; 2007 Oct; 27(5):484-93. PubMed ID: 18018485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
    Kaindlstorfer C; Sommer P; Georgievska B; Mather RJ; Kugler AR; Poewe W; Wenning GK; Stefanova N
    Neurotox Res; 2015 Oct; 28(3):185-94. PubMed ID: 26194617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropathology, pathophysiology and genetics of multiple system atrophy.
    Ahmed Z; Asi YT; Sailer A; Lees AJ; Houlden H; Revesz T; Holton JL
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):4-24. PubMed ID: 22074330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.